Invesco Biotechnology & Genome ETF
PBE
#2120
ETF Rang
€0.22 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
72,42 €
Aktienkurs
-0.83%
Veränderung (1 Tag)
29.10%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 4. Juni 2026Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
5.06%
Amgen IncAMGN37838
5.02%
Alnylam Pharmaceuticals IncALNY43016
5.00%
Royalty Pharma PLCRPRX236006
4.97%
Biogen IncBIIB65834
4.95%
Vertex Pharmaceuticals IncVRTX29159
4.84%
Regeneron Pharmaceuticals IncREGN20030
4.72%
Gilead Sciences IncGILD95052
4.63%
United Therapeutics CorpUTHR21975
3.09%
Legend Biotech CorpLEGN234793
3.08%
Illumina IncILMN47743
3.01%
Veracyte IncVCYT156829
2.95%
Bio-Techne CorpTECH144537
2.93%
Repligen CorpRGEN60191
2.86%
Neurocrine Biosciences IncNBIX44522
2.86%
CareDx IncCDNA321886
2.85%
BioMarin Pharmaceutical IncBMRN131116
2.82%
QIAGEN NVQGEN195088.3786
2.80%
Exelixis IncEXEL138724
2.78%
PTC Therapeutics IncPTCT102490
2.78%
Incyte CorpINCY71405
2.78%
Halozyme Therapeutics IncHALO100894
2.74%
Protagonist Therapeutics IncPTGX69348
2.72%
ACADIA Pharmaceuticals IncACAD326125
2.72%
Vericel CorpVCEL198268
2.66%
BioCryst Pharmaceuticals IncBCRX818586
2.66%
Sarepta Therapeutics IncSRPT415922
2.58%
Collegium Pharmaceutical IncCOLL205253
2.38%
AnaptysBio IncANAB120018
2.34%
Omeros CorpOMER595144
2.30%
Ardelyx IncARDX1109348
0.13%
Invesco Government & Agency PortfolioAGPXX327170.89
-0.02%
CASH & EQUIVALENTSUSD-49392.14